Search Results: keywords:"patent infringement"

  • S. 3583 — To address patent thickets.
    Status:Introduced in Senate
    Words:676

    S. 3583 is a bill aimed at addressing "patent thickets" by limiting the number of patents that can be asserted in certain legal actions. The bill amends section 271(e) of title 35 of the United States Code to restrict patent holders to asserting only one patent per "Patent...

    Simple Explanation

    S. 3583 is a bill that tries to make it fairer for companies to make medicines by stopping other companies from using too many similar patents to block them. It says that if someone wants to complain about a patent related to a new drug, they can only talk about one patent at a time.

  • S. 150 — An Act To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
    💰
    Status:Engrossed in Senate
    Words:1,182

    S. 150 aims to modify the Federal Trade Commission Act to stop product hopping. The bill introduces changes to patent laws concerning biological products, restricting the number of patents that can be asserted in infringement cases and specifying conditions under which courts...

    Simple Explanation

    S. 150 is like a rule that tries to stop companies from sneaking around with medicine products, and it also gives a lot of money to help make a health program called Medicare better.

  • H. R. 9070 — To amend title 35, United States Code, to prohibit product hopping, and for other purposes.
    💰
    Status:Introduced in House
    Words:1,245

    H.R. 9070, known as the "Affordable Prescriptions for Patients Act of 2024," aims to amend Title 35 of the United States Code to make it harder for companies to engage in "product hopping," a strategy used to delay generic competition for pharmaceuticals. The bill allows the sponsor of an...

    Simple Explanation

    H.R. 9070 is a bill that plans to stop medicine companies from using tricks to keep their drugs more expensive for longer and adds a lot of money to help old people get healthcare through Medicare.

  • H. R. 9221 — To amend title 35, United States Code, to establish a rebuttable presumption that a permanent injunction should be granted in certain circumstances, and for other purposes.
    Status:Introduced in House
    Words:679

    H. R. 9221, also known as the "RESTORE Patent Rights Act of 2024," aims to amend title 35 of the United States Code to reinforce patent rights by establishing a rebuttable presumption that a permanent injunction should be issued when a patent is infringed. The bill emphasizes the importance...

    Simple Explanation

    The "RESTORE Patent Rights Act of 2024" suggests changes to help inventors by making it easier for them to stop others from using their inventions without permission, but some worry that it might not always be fair or clear how this will work in court.

  • S. 1041 — To amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.
    Status:Introduced in Senate
    Words:1,192

    S. 1041 is a bill that aims to update U.S. patent laws regarding biological products to address patent infringement issues. It allows the sponsor of a biologic drug reference product to sue an applicant for a similar product for infringement on a limited number of patents,...

    Simple Explanation

    S. 1041 is a bill that wants to change some rules about biological medicines so that people who make them can protect their ideas but still let others try to make similar medicines in a fair way.

  • S. 5573 — To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
    Status:Introduced in Senate
    Words:1,137

    S. 5573 aims to change title 35 of the United States Code to create a "safe harbor" that protects certain actions from being considered patent infringement. Specifically, it protects companies that apply to sell generic or biosimilar versions of drugs or biological products...

    Simple Explanation

    The bill wants to make it okay for companies to sell cheaper versions of medicines without getting in trouble for using someone else's idea, as long as they don't copy certain special uses from the original. It also wants this rule to work for things done before, now, or in the future.

  • H. R. 1574 — To amend title 35, United States Code, to establish a rebuttable presumption that a permanent injunction should be granted in certain circumstances, and for other purposes.
    Status:Introduced in House
    Words:675

    H. R. 1574, also known as the "RESTORE Patent Rights Act of 2025," aims to amend title 35 of the United States Code to support patent owners by establishing a rebuttable presumption in favor of granting permanent injunctions when a patent infringement is determined by the...

    Simple Explanation

    In the RESTORE Patent Rights Act of 2025, the rule says if someone uses someone else's invention without asking, the court should usually make them stop unless they can give a really good reason. This is to help inventors, especially the smaller ones, protect their ideas.

  • S. 43 — To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
    Status:Introduced in Senate
    Words:1,131

    S. 43 aims to amend U.S. patent law to create a "safe harbor" that protects companies from patent infringement claims when they submit applications for generic or biosimilar drugs or market them if certain conditions are met. Specifically, the bill ensures that actions like...

    Simple Explanation

    S. 43 is a bill that wants to make it easier for companies to sell cheaper versions of medicine by saying they won't get in trouble for using certain ideas, as long as they don’t copy the special parts of the original medicine.

  • S. 4840 — To amend title 35, United States Code, to establish a rebuttable presumption that a permanent injunction should be granted in certain circumstances, and for other purposes.
    Status:Introduced in Senate
    Words:666

    S. 4840 aims to change how courts handle patent infringement cases by establishing a rebuttable presumption that a permanent injunction should be granted when a patent is found to be infringed. This means that, once infringement is confirmed, the patent holder is assumed to...

    Simple Explanation

    In this bill, if someone makes something that's already protected by your patent, it's assumed that the court should stop them. But, if they can show a good reason they should keep going, they might be allowed to continue.

  • S. 1041 — To amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.
    Status:Reported to Senate
    Words:1,283

    S. 1041, also known as the “Affordable Prescriptions for Patients Act,” seeks to change patent laws to address how patents for biological products are handled when there's an accusation of patent infringement. The bill specifically limits the number of patents a reference...

    Simple Explanation

    The Affordable Prescriptions for Patients Act is a new rule that tries to make medicine cheaper by changing how many patents a company can use when they argue about who invented a medicine made from living things. It also sets limits to help keep the fight fair so everyone can get the medicine they need.

  • S. 708 — To amend title 35, United States Code, to establish a rebuttable presumption that a permanent injunction should be granted in certain circumstances, and for other purposes.
    Status:Introduced in Senate
    Words:666

    S. 708 aims to modify U.S. patent law to make it easier to obtain a permanent injunction when a patent is infringed upon. The bill intends to reintroduce a rule where courts presume that an injunction should be issued against patent infringers, unless the accused infringer...

    Simple Explanation

    This bill wants to make a rule that if someone is using another person's invention without permission, the court should usually stop them, unless they can show a good reason not to. It's meant to help inventors, especially small ones, protect their ideas from being used by big companies.